Overview

Effectiveness of Mineral Trioxide Aggregate and Platelet Rich Fibrin Along With Biodentine. .

Status:
Completed
Trial end date:
2021-03-12
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study was to clinically and radiographically evaluate the effectiveness of MTA, Biodentine, Platelet Rich Fibrin along with Mineral Trioxide Aggregate and Platelet Rich Fibrin along with Biodentine as pulpotomy medicament in patients with pulpitis.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Maharishi Markendeswar University (Deemed to be University)
Criteria
Inclusion Criteria:

- Patients with carious exposed tooth exhibiting clinical and radiographical evidence
for pulpitis.

- Deep caries extending ≥2/3 of dentin.

- Tooth with positive response with cold testing.

- Tooth with no mobility.

- No signs of pulpal necrosis including sinus tract or swelling.

- Patient approval for the treatment and follow up

Exclusion Criteria:

- Any systemic disease that could influence the outcome.

- Non-restorable tooth.

- Teeth with periapical widening.

- Tooth which cannot be isolated.

- Teeth with marginal periodontitis or crestal bone loss.

- Indication of post/ post and core restoration marginal periodontitis with attachment
loss >5mm.

- Teeth with immature root or calcified canal.

- Teeth with internal and external resorption.

- No pulp exposure after caries excavation.

- Uncontrolled bleeding after access cavity preparation after several minutes N

- No bleeding at all at the time of access opening

- Pregnant or nursing women.

- Individual hypersensitive or allergic to any product used in the study